180
Participants
Start Date
September 23, 2025
Primary Completion Date
February 1, 2027
Study Completion Date
February 1, 2027
Ropivacaine
Patients in this group will receive CINB (continuous local intercostal infusion of 0.2% Ropivacaine). A single catheter will be placed for short segment involvement and two catheters will be placed in series for longer segments of involvement. If necessary and as part of standard of care, CINB treatment will continue after patient discharge. The administration of CINB therapy will continue in the same manner as inpatient therapy.
Non steroidal anti-inflammatory drug and opioids
Patients in this group receive nonsteroidal and opioid pain medications (intravenous/oral inpatient and oral outpatient) per standard of care.
RECRUITING
University of Kentucky Medical Center, Lexington
Zachary Warriner
OTHER